A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...
Shaji Kumar, MD, Mayo Clinic, highlights linvoseltamab’s dosing regimen, adverse effect profile, and management strategies. He speaks in particular about cytokine release syndrome, which although ...
Antibody-based immune therapy could become a key weapon in the fight against bird flu after trials in monkeys successfully prevented severe illness and death from the infection. The preventative ...
Explore the transformative potential of bispecific antibodies in multiple myeloma, offering hope for improved patient ...
For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist antibodies. On paper, they looked like a breakthrough. In mice and other lab ...
From hair regrowth to safe pregnancy chemotherapy and new targeted therapies, these top five breast cancer stories of 2025 ...
As the U.S. grapples with the lasting effects of the Covid-19 pandemic, it is important to highlight the ongoing challenges faced by the 7 million immunocompromised Americans. For them, the battle ...
The 35-year-old woman initially presented to a rheumatologist in October 2022 with typical Raynaud's phenomenon affecting her hands. Capillaroscopy revealed a characteristic SSc pattern with decreased ...
The pause affects Sotrovimab from GlaxoSmithKline. The federal government is sharply pulling back on one of the monoclonal antibody treatments authorized for COVID-19, pausing its use across eight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback